Evidence map›Paper›PMID 19765883›Full record

ReviewArchivos de bronconeumologia2010

[Role of toll-like receptors in respiratory diseases].

Astrid Crespo-Lessmann, Cándido Juárez-Rubio, Vicente Plaza-Moral

Registry-linked trialOpen access · greenAbstract readEnglish AbstractReview
In one paragraph

Review in Archivos de bronconeumologia, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT02028637 (Expression of Toll-Like Receptors 2 and 4 in Asthmatic Patients.), which is not on this map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
1.0field-weighted citation impact, top 21% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT02028637 nacompletednot on this map

Expression of Toll-Like Receptors 2 and 4 in Asthmatic Patients.

TypeinterventionalSponsorFundació Institut de Recerca de l'Hospital de la Santa Creu i Sant PauRan2009 to 2013Enrolled59ConditionsAsthmaArmsTLRs
3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 12 citations in OpenAlex.

  1. Common virulence factors betweenCurrent research in microbial sciences · 2024
    Review
  2. Effects of Inhaled Corticosteroids on the Innate Immunological Response toInternational journal of molecular sciences · 2022
    Article
  3. Article
  4. Article
  5. Observational
  6. Article
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Astrid Crespo-LessmannServicio de Neumología, Hospital de Santa Creu i Sant Pau, Barcelona, España.
Cándido Juárez-Rubio
Vicente Plaza-Moral
Hospital de Sant Pau · ES

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

There has been growing interest in the last 10 years in the study of innate immunity, in particular because of the possible role that toll-like receptors (TLR) may play in the pathogenesis of some respiratory disease such as for example, asthma, chronic obstructive pulmonary disease, and infections. TLR are a family of type 1 transmembrane proteins, responsible for recognizing molecular patterns associated with pathogens (PAMP, pathogen-associated molecular patterns), and expressed by a broad spectrum of infectious agents. This recognition leads to quick production of cytokines and chemokines which provides a long-lasting adaptive response to the pathogen. Currently, it is considered that the administration of drugs which modulate the activity of these receptors upwards or downwards may represent major therapeutic progress for handling these diseases. The aim of this review is to describe the different TLS, define their possible role in the pathogenesis of the main respiratory diseases and finally, speculate over the therapeutic possibilities which their modulation, agonist or antagonist, offers as possible therapeutic targets.

Indexed as

ChemokinesCytokinesHumansRespiratory Tract DiseasesToll-Like ReceptorsChemokinesCytokinesToll-Like Receptors

Identifiers

PMID19765883
PMCPMC7115790
OpenAlexW2120776043

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.